UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________
FORM 6-K
__________________
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For
the month of September 2024
Commission File Number: 001-41524
___________________________________
Rentokil Initial plc
(Registrant’s name)
___________________________________
Compass House
Manor Royal
Crawley
West Sussex RH10 9PY
United Kingdom
(Address of principal executive office)
_____________________________________
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T
Rule 101(b)(1): ☐
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T
Rule 101(b)(7): ☐
|
Appointment
of Non-Executive Director dated 25 September 2024
|
|
25 September 2024
Appointment of Non-Executive Director
Rentokil Initial plc (FTSE: RTO, "the Company") today announces the
appointment of Brian Baldwin to its Board as a Non-Executive
Director with effect from 1 October 2024. He will also become a
member of the Nomination Committee and Remuneration Committee from
this date.
Mr. Baldwin is the Head of Research of Trian Fund Management, L.P.
("Trian"), an investment management firm. Mr Baldwin has been a
Trian Partner since 2013 and a member of Trian's Investment Team
since 2007. He has played leadership roles in many of Trian's
investments.
Mr. Baldwin has been a non-executive director of Janus Henderson
Group plc since 2022 and currently serves on the Board's Nominating
and Corporate Governance Committee and the Risk Committee. From
2018 to 2020, he served as a director and member of the
Compensation and Governance Committees of nVent Electric plc
(formerly the electrical business of Pentair plc before becoming a
standalone public company).
Prior to joining Trian, Mr. Baldwin was an analyst at Merrill Lynch
Global Private Equity from 2005 to 2007. Mr. Baldwin received a
B.S. degree, summa cum laude, from The Wharton School at the
University of Pennsylvania.
Richard Solomons, Chairman of Rentokil Initial, said:
"We are delighted to welcome Brian to the Board of Rentokil Initial
and we look forward to working with him to deliver long-term
sustainable value for our shareholders and, in particular,
executing our plans to integrate the Terminix business and to
increase organic growth in our North America operations. We
continue to work towards the substantial structural growth
opportunities for our pest control business, enhanced by the
benefits of the Terminix transaction."
Brian Baldwin said:
"I welcome the opportunity to join the Board of Rentokil Initial.
Trian believes Rentokil has significant potential and runway for
growth that can be achieved by leveraging its strong brands and
market leading positions, particularly in the US. I look forward to
working with management and the Board to identify options to help
drive long-term value that will benefit all
stakeholders."
Trian has confirmed to the Company that it manages investment
vehicles owning approximately 57.1 million shares of Rentokil
Initial (approximately
2.26% of shares outstanding).
There are no further details to be disclosed relating to Brian
Baldwin under Section 6.4.8 of the UK Listing Rules.
For further information please contact:
Rentokil Initial plc
|
Investors
|
Peter Russell
|
07795 166506
|
|
Media
|
Malcolm Padley
|
07788 978 199
|
|
Company Secretary
|
Rachel Canham
|
01293 858 000
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
Date:
25 September 2024
|
RENTOKIL INITIAL PLC
|
|
|
/s/
Rachel Canham
|
|
|
Name:
Rachel Canham
|
|
|
Title:
Group General Counsel and Company Secretary
|
|
|
|